Compare CET & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CET | ASTH |
|---|---|---|
| Founded | 1929 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Professional Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2015 |
| Metric | CET | ASTH |
|---|---|---|
| Price | $55.25 | $35.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $34.86 |
| AVG Volume (30 Days) | 24.1K | ★ 328.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 5.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $519,907,752.00 |
| Revenue This Year | N/A | $27.38 |
| Revenue Next Year | N/A | $10.78 |
| P/E Ratio | ★ $6.93 | $50.91 |
| Revenue Growth | N/A | ★ 45.90 |
| 52 Week Low | $47.82 | $18.08 |
| 52 Week High | $57.39 | $51.60 |
| Indicator | CET | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 48.49 | 42.96 |
| Support Level | $55.12 | $33.92 |
| Resistance Level | $55.74 | $40.08 |
| Average True Range (ATR) | 0.85 | 1.91 |
| MACD | -0.10 | -0.09 |
| Stochastic Oscillator | 10.08 | 37.84 |
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.